The field of nonprecious metal catalysis (NPMC) continues to provide alternatives to transformations that are traditionally mediated by precious metals, as well as reactivity unique to the first-row transition metals. These advances are of interest due to their lower cost, better sustainability, and expanding range of applications. This review is part of a triannual series published by chemists from AbbVie, Boehringer-Ingelheim, and Pfizer focused on NPMC articles selected for their utility to the chemical and pharmaceutical industries from November 2024 to February 2025.
Allais et al. (Tue,) studied this question.